Family Medicine Doctors in Moorefield, WV Accepting Medicare
5 Family Medicine doctors found. Showing 1 - 5
 Mrs. Kelly D Smith-riggleman, PAC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Kuykendall Ln, Moorefield, WV 26836 Phone: 304-530-7755 Fax: 304-530-7756 |
Jessica Marie Riggleman, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 747 N Main St Ste C, Moorefield, WV 26836 Phone: 304-538-8000 Fax: 304-538-8014 |
Donna R Fisher, CANP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Kuykendall Lane, Moorefield, WV 26836 Phone: 304-530-7755 Fax: 304-530-7756 |
Natalie Hardy, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 112 Kuykendall Ln, Moorefield, WV 26836 Phone: 304-530-7755 Fax: 304-530-7756 |
 Michael P Riggleman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Kuykendall Ln, Moorefield, WV 26836 Phone: 304-530-7755 |
News Archive
AS03 and MF59 adjuvants increase immune responses to two doses of H7N9 influenza vaccine
In a phase 2 trial that included nearly 1,000 adults, the AS03 and MF59 adjuvants (a component that improves immune response of inactivated influenza vaccines) increased the immune responses to two doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest amount of antibody response, according to a study in the July 21 issue of JAMA.
Recent releases: PEPFAR in Zimbabwe; dengue in Thailand; blogs on improving U.S. foreign aid; examining allocations of health aid
The U.S. plans to support efforts to develop a sustainable health system in Zimbabwe and increase its capacity to treat people, Eric Goosby, U.S. global AIDS Coordinator for PEPFAR, said on Wednesday after a visit to the country with USAID and CDC officials, according to a press release from the U.S. Embassy in Harare, Zimbabwe. Goosby said he is "optimistic" that the Zimbabwe PEPFAR team's experience will be used "to develop a response that fits the existing health infrastructure, supports it and reinforces it in a way that creates a durable and lasting response" (9/2).
New investigational inhibitor JQEZ5 can block specific molecular malfunctions driving cancer
In a step forward in the push for targeted treatments that can block the specific molecular malfunctions driving cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers have demonstrated how a genetic mutation can drive the most common type of lymphoma as well as melanoma, the deadliest form of skin cancer.
Genesis Bioventures signs agreement for control of Mad Cow diagnostic company
Further to a Letter of Intent previously reported, Genesis Bioventures today announced that it has entered into a binding agreement with Efoora Inc. and Prion Developmental Laboratories, Inc. to buy all of Efoora's majority interest shares owned or pledged in PDL thereby gaining controlling interest of PDL. A Form 8-K has been filed with the SEC in this regard. Prior to the Agreement, GBI had one-third equity interest in PDL.
Columbia University receives CFI grant to investigate causes of chronic fatigue syndrome
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
› Verified 1 days ago
Family Medicine
Emergency Medicine
Pediatrics
General Practice